Top

Published in:

01-05-2022 | Losartan | Clinical study

ADR reporting rate greater for valsartan than other ARBs

Published in: Reactions Weekly | Issue 1/2022

Excerpt

The suspected adverse drug reaction (ADR) reporting rate is greater for valsartan than for other angiotensin II receptor blockers (ARBs), according to findings of a study published in BJCP, the British Journal of Pharmacology. …

Salim H, et al. Angiotensin II Receptor Blockers (ARBs) and Manufacturing Contamination: A Retrospective National Register Study into suspected associated adverse drug reactions British Journal of Clinical Pharmacology : 23 May 2022. Available from: URL: http://doi.org/10.1111/bcp.15411

Title: ADR reporting rate greater for valsartan than other ARBs
Publication date: 01-05-2022
Publisher: Springer International Publishing
Keywords: Losartan
Eprosartan
Valsartan
Candesartan
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-15733-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

ADR reporting rate greater for valsartan than other ARBs

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Etizolam abuse and overdose

Cabergoline/temozolomide

Bortezomib

Ledipasvir/sofosbuvir

Mesalazine

Amiodarone/camrelizumab/nifekalant